| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 656038 | 98085024 | KARVEZIDE 300 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | KARVEZIDE 300 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 300 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98085024/98085024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98085024/98085024_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2006-09-19 | 1 | 1 | 1 | 2006-09-19 | 2006-09-19 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 656355 | 98070001 | ISCOVER 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ISCOVER 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 75 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98070001/98070001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98070001/98070001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 1999-02-01 | 1 | 1 | 1 | 1999-02-01 | 1999-02-01 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 656939 | 06363004 | SPRYCEL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SPRYCEL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06363004/06363004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06363004/06363004_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2006-11-29 | 1 | 1 | 1 | 2006-11-29 | 2009-12-23 | 1 | 2011-10-18 | 656418 | View Edit Delete | |||||||||||
| 658226 | 68316 | CLOBEX 500 microgramos/g CHAMPU | CLOBEX 500 microgramos/g CHAMPU , 1 frasco de 125 ml | 0,5 mg/g | 6 | 125 | 26 | 1 frasco de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68316/68316_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68316/68316_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23643 | LABORATORIOS GALDERMA S.A. | 2007-01-19 | 1 | 1 | 1 | 2007-01-19 | 2007-01-19 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 660248 | 69475 | DICLOABAK 1 mg/ml COLIRIO EN SOLUCION | DICLOABAK 1 mg/ml COLIRIO EN SOLUCION, 1 frasco de 10 ml (PE) | 1 mg/ml | 6 | 10 | 26 | 1 frasco de 10 ml (PE) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69475/69475_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69475/69475_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27777 | LABORATORIOS THEA S.A. | 2007-12-14 | 1 | 1 | 1 | 2007-12-17 | 2007-12-14 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 659170 | 07389001 | ORENCIA 250 mg POLVO PARA CONCENTRADO PARA SOL. PARA PERFUSION | ORENCIA 250 mg POLVO PARA CONCENTRADO PARA SOL. PARA PERFUSION, 1 vial | 250 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07389001/07389001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07389001/07389001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-06-15 | 1 | 1 | 1 | 2007-06-15 | 2007-06-15 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 660197 | 69445 | EPIDUO 1 mg/g + 25 mg/g GEL | EPIDUO 1 mg/g + 25 mg/g GEL , 1 tubo de 60 g | 1 mg/g + 25 mg/g | 67 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69445/69445_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69445/69445_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23643 | LABORATORIOS GALDERMA S.A. | 2008-02-11 | 1 | 1 | 1 | 2008-02-11 | 2008-02-11 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 661678 | 62001 | SOTAPOR 80 mg COMPRIMIDOS | SOTAPOR 80 mg COMPRIMIDOS , 30 comprimidos | 80 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62001/62001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62001/62001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 660348 | 69522 | AZYDROP 15mg/g, COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | AZYDROP 15mg/g, COLIRIO EN SOLUCION EN ENVASE UNIDOSIS , 6 envases unidosis de 0,25 g | 15 mg/g | 37 | 6 | 16 | 6 envases unidosis de 0,25 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69522/69522_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69522/69522_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27777 | LABORATORIOS THEA S.A. | 2008-01-17 | 1 | 1 | 1 | 2008-01-17 | 2008-01-17 | 0 | 2011-10-18 | View Edit Delete | ||||||||||||
| 660921 | 08448001 | MYCAMINE 50 mg POLVO PARA SOLUCION PARA PERFUSION | MYCAMINE 50 mg POLVO PARA SOLUCION PARA PERFUSION , 1 vial | 50 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08448001/08448001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08448001/08448001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12611 | BEXAL FARMACEUTICA S.A. | 2008-05-26 | 1 | 1 | 1 | 2008-05-26 | 2008-05-26 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 660922 | 08448002 | MYCAMINE 100 mg POLVO PARA SOLUCION PARA PERFUSION | MYCAMINE 100 mg POLVO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08448002/08448002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08448002/08448002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12611 | BEXAL FARMACEUTICA S.A. | 2008-05-26 | 1 | 1 | 1 | 2008-05-26 | 2008-05-26 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 662572 | 66881 | LACOVIN 50 mg/ml SOLUCIÓN CUTÁNEA | LACOVIN 50 mg/ml SOLUCIÓN CUTÁNEA , 2 frascos de 60 ml | 50 mg/ml | 6 | 120 | 26 | 2 frascos de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66881/66881_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66881/66881_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23643 | LABORATORIOS GALDERMA S.A. | 2005-06-16 | 1 | 1 | 1 | 2005-06-16 | 2009-03-17 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 663145 | 09523001 | MODIGRAF 0,2 mg GRANULADO PARA SUSPENSION ORAL | MODIGRAF 0,2 mg GRANULADO PARA SUSPENSION ORAL, 50 sobres | 0,2 mg | 35 | 50 | 64 | 50 sobres | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09523001/09523001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09523001/09523001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2009-07-30 | 1 | 1 | 1 | 2009-07-30 | 2009-07-30 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 663147 | 09523002 | MODIGRAF 1 mg GRANULADO PARA SUSPENSION ORAL | MODIGRAF 1 mg GRANULADO PARA SUSPENSION ORAL, 50 sobres | 1 mg | 35 | 50 | 64 | 50 sobres | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09523002/09523002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09523002/09523002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2009-07-30 | 1 | 1 | 1 | 2009-07-30 | 2009-07-30 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 664010 | 70710 | MYDRIASERT 0,28 mg/5,4 mg INSERTO OFTALMICO | MYDRIASERT 0,28 mg/5,4 mg INSERTO OFTALMICO, 1 implante | 0,28 mg/5,4 mg | 35 | 1 | 23 | 1 implante | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70710/70710_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70710/70710_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 27777 | LABORATORIOS THEA S.A. | 2009-09-30 | 1 | 1 | 1 | 2009-09-30 | 2009-09-30 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 669473 | 61633 | HYDREA 500 mg CAPSULAS DURAS | HYDREA 500 mg CAPSULAS DURAS, 20 cápsulas | 500 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61633/61633_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61633/61633_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 1998-05-01 | 1 | 1 | 1 | 1998-05-01 | 1998-05-01 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 669549 | 60748 | COD-EFFERALGAN 500 mg/ 30 mg comprimidos efervescentes | COD-EFFERALGAN 500 mg/ 30 mg comprimidos efervescentes , 20 comprimidos | 500 mg/30 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60748/60748_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60748/60748_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16744 | NEWLINE PHARMA S.L.U. | 1996-03-01 | 1 | 1 | 1 | 1996-03-01 | 1997-08-01 | 1 | 2011-10-18 | 653840 | Lista III | View Edit Delete | ||||||||||
| 671990 | 61510 | EFFERALGAN 1 G COMPRIMIDOS EFERVESCENTES | EFFERALGAN 1 G COMPRIMIDOS EFERVESCENTES , 8 comprimidos | 1.000 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61510/61510_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61510/61510_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16744 | NEWLINE PHARMA S.L.U. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 673541 | 49818 | NIFLACTOL 250 mg CAPSULAS | NIFLACTOL 250 mg CAPSULAS, 30 cápsulas | 250 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49818/49818_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49818/49818_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16744 | NEWLINE PHARMA S.L.U. | 1972-02-01 | 1 | 1 | 1 | 1972-02-01 | 1996-12-01 | 0 | 2011-10-18 | View Edit Delete | ||||||||||||
| 674010 | 61387 | BENZAC WASH 50 MG/G GEL | BENZAC WASH 50 MG/G GEL , 1 tubo de 100 g | 50 mg/g | 44 | 100 | 21 | 1 tubo de 100 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61387/61387_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61387/61387_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23643 | LABORATORIOS GALDERMA S.A. | 1997-05-01 | 1 | 1 | 1 | 1997-05-01 | 1997-05-01 | 1 | 2011-10-18 | View Edit Delete |
Page 163 of 1035, showing 20 records out of 20697 total, starting on record 3241, ending on 3260